ArticleClinical ophthalmology (Auckland, N.Z.)2019

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.

Raymond Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.